home





























 

















 





















hrsa

participating institutions:
Johns Hopkins University AIDS Service, New York State DOH AIDS Institute, The CORE Center, Cook County Hospital



NEWS AND NEW DEVELOPMENTS



Experts debate broad drug prophylaxis policy for HIV infected in Africa [Stencel C. ASM News 2001;67:131]: TMP-SMX costs $8-$17/person/year, has established merit including two favorable studies done in Cote d'Ivoire and is supported by the CDC, Doctors Without Borders, and UNAIDS. Nevertheless, concern is expressed that it may not work as well in all areas of Africa and there is the problem of escalating antibiotic resistance to TMP-SMX by Salmonella and S. pneumoniae. WHO and UNAIDS have finalized their policy statement recommending cotrimoxazole be made available for daily use among HIV-infected persons throughout Africa. Nevertheless, the issue is still debated.
posted 3/20/2001





Copyright © 2001. The National AIDS Education and Training Centers Program on behalf of its AETC National Resource Center. All rights reserved.

Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need, and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have.